The purpose of this funding opportunity announcement (FOA) is to support critical enabling resources that will accelerate new research discoveries and/or implementation of research discoveries in pharmacogenomics.
A proposed resource must meet an ascertained community demand and benefit the entire
credit:
scientific field of users.
The FOA will support activities that can be clearly and specifically defined, are optimally designed, have evaluative measures built-in, are judiciously staffed, have formed partnerships where appropriate, and ideally have a proven track record and a finite lifetime.
The outcome of an enabling resource must be highly impactful in a demonstrable way.
Advance consultation with Scientific/Research staff to ensure that a proposed resource fits well with this opportunity is highly encouraged.